References and Notes
-
1a
Gilchrist TL.
d’A
Rocha Gonsalves AM.
Pinho e Melo TMVD.
Pure Appl. Chem.
1996,
68:
859
-
1b
Sommer S.
Angew.
Chem.
1979,
91:
756
-
1c
Boeckmann RK.
Reed JE.
Ge P.
Org. Lett.
2001,
3:
3647
-
1d
Attanasi OA.
De Crescentini L.
Filippone P.
Mantellini F.
Santeusanio S.
ARKIVOC
2002,
(xi):
274
-
2a
South M.
Jakuboski TL.
Tetrahedron
Lett.
1995,
36:
5703
-
2b
Attanasi OA.
De Crescentini L.
Filippone P.
Fringuelli F.
Mantellini F.
Mattucci M.
Piermatti O.
Pizzo F.
Helv.
Chim. Acta
2001,
84:
513
-
2c
Abbiati G.
Attanasi OA.
Rizzato S.
Rossi E.
Santeusanio S.
Tetrahedron
2007,
63:
11055
-
2d
Attanasi OA.
Favi G.
Filippone P.
Perrulli FR.
Santeusanio S.
Org. Lett.
2009,
11:
309
-
3a
Attanasi OA.
De Crescentini L.
Favi G.
Filippone P.
Mantellini F.
Perrulli FR.
Santeusanio S.
Eur.
J. Org. Chem.
2009,
3109
-
3b
Attanasi OA.
Cotarca L.
Favi G.
Filippone P.
Perrulli FR.
Santeusanio S.
Synlett
2009,
1583
-
3c
Polanc S. In Targets in Heterocyclic Systems: Chemistry
and Properties
Vol. 3:
Attanasi OA.
Spinelli D.
Società Chimica
Italiana;
Rome:
2000.
p.33-92
-
3d
Banert K. In Targets in Heterocyclic Systems: Chemistry
and Properties
Vol. 3:
Attanasi OA.
Spinelli D.
Società Chimica
Italiana;
Rome:
2000.
p.1-32
- 4
Attanasi OA.
Filippone P.
Foresti E.
Guidi B.
Santeusanio S.
Tetrahedron
1999,
55:
13423
- 5
Attanasi OA.
Carvoli G.
Filippone P.
Perrulli FR.
Santeusanio S.
Synlett
2004,
1643
-
6a
Patel PB.
Trivedi JT.
Indian Chem. Soc.
1987,
54:
765
-
6b
Vittoria DM.
Mazzoni O.
Piscopo E.
Caligmano A.
Bolognese A.
J. Med. Chem.
1992,
35:
2910
-
6c
Omar AM.
Eshba NH.
J.
Pharm. Sci.
1993,
82:
387
-
6d
Hassan HY.
El-Koussi NA.
Farghaly ZSM.
Chem. Pharm. Bull.
1998,
46:
863
-
6e
Turan-Zitouni G.
Sivaci DM.
Kaplancikli ZA.
Ozdemir A.
Farmaco
2002,
57:
569
-
6f
Bonde CG.
Gaikwad NJ.
Bioorg. Med.
Chem.
2004,
12:
2151
-
6g
Bodtke A.
Pfeiffer W.-D.
Ahrens N.
Langer P.
Bioorg. Med. Chem. Lett.
2004,
142:
1509
-
7a
Hantzsch A.
Weber JH.
Ber.
Dtsch. Chem. Ges.
1887,
20:
3118
-
7b
Traumann V.
Liebigs
Ann. Chem.
1888,
31
-
7c
Weitzberg M.
Aizensthat Z.
Blum J.
J.
Heterocycl. Chem.
1984,
21:
1597
- 8
Beyer H.
Ruhling G.
Chem. Ber.
1956,
89:
107
- 9
De Kimpe N.
Boelens M.
Declercq JP.
Tetrahedron
1993,
49:
3411
- 10
Arcadi A.
Attanasi OA.
Giorgi G.
Filippone P.
Rossi E.
Santeusanio S.
Tetrahedron Lett.
2003,
44:
8391
- 11
Yadav LDS.
Patel R.
Rai VK.
Srivastava VP.
Tetrahedron
Lett.
2007,
48:
7793
-
12a
Schantl JG.
Prean M.
Monatsh.
Chem.
1993,
124:
299
-
12b
Schantl JG.
Lagoja IM.
Heterocycles
1997,
45:
691
-
12c
Schantl JG.
Nádeník P.
Synlett
1998,
786
13
Typical One-Pot
Procedure for the Preparation of 2-Imino-4-thiazoline
Derivatives 4a-k
The requisite 1,2-diaza-1,3-butadiene 1a-k (1
mmol), prepared and used as an E,E/E,Z isomer mixture,¹c was added
to a solution of KSCN (106.7 mg, 1.1 mmol) in glacial AcOH (2 mL)
under magnetic stirring. The consumption of 1a-k was rapid and TLC analysis indicated
the presence one major product. The reaction mixture was allowed
to stand at r.t. overnight to allow complete conversion of the Michael adduct
into the corresponding 2-imino-4-thiazoline derivative. AcOH was
removed in vacuo, the residue was dissolved in H2O,
and the solution neutralized with sat. Na2CO3.
Compounds 4a-c,e,g-i were obtained by extraction of the aqueous
phase with Et2O. The dried organic layers were filtered
and evaporated, and the crude compounds were isolated as powders
or foams and purified by recrystallization or by flash chromatography
on silica. Compounds 4d,f,j,k, precipitated
from the aqueous medium after addition of sat. Na2CO3 and
were isolated by filtration and recrystallized from an appropriate
solvent mixture
14
Data for
tert
-Butyl-2-[3-(dimethylamino)-1-methyl-3-oxo-2-thiocyanatopropylidene]hydrazinecarboxylate (3j)
White
powder from EtOAc-cyclohexane; mp 139-140 ˚C (dec.).
IR (KBr): 3467, 3331, 2153, 1746, 1650, 1503 cm-¹. ¹H
NMR (400 MHz, DMSO-d
6): δ = 1.45
(s, 9 H, Ot-Bu), 1.86 (s, 3 H, CH3),
2.86 and 2.97 [2 s, 6 H, N(CH3)2],
5.79 (s, 1 H, CH), 10.00 (s, 1 H, NH). ¹³C
NMR (100 MHz DMSO-d
6): δ = 12.3
(q), 28.0 (q), 35.9 (q), 37.1 (q), 61.0 (d), 79.8 (s), 112.4 (s),
144.9 (s), 152.6 (s), 164.7 (s). ESI-MS:
m/z calcd
for C12H20N4O3S: 300.4;
found: 301 [M + 1].
15
Data for
tert
-Butyl {5-[(Dimethylamino)carbonyl]-2-imino-4-methyl-1,3-thiazol-3
(2
H
)-yl}carbamate
(4j)
White powder from EtOAc-cyclohexane;
mp 159-160 ˚C (dec.). IR (KBr): 3318,
3255, 3203, 1736, 1631, 1606 cm-¹. ¹H
NMR (400 MHz, DMSO-d
6): δ = 1.38
and 1.43 (2 s, 9 H, Ot-Bu), 1.89 (s,
3 H, CH3), 2.93 [s, 6 H, N(CH3)2],
8.18 (br s, 1 H, NH), 9.64 (br s, 1 H, NH). ¹³C
NMR (100 MHz DMSO-d
6): δ = 12.7
(q), 27.6 and 27.8 (2 q), 36.6 (q), 40.1 (q), 80.5 (s), 98.5 (s),
136.9 (s), 154.6 (s), 157.9 (s), 162.8 (s). ESI-MS: m/z calcd for C12H20N4O3S:
300.4; found: 301 [M + 1].